mechlorethamine has been researched along with Local Neoplasm Recurrence in 81 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous investigators have reported responses in 52% of patients treated with mechlorethamine (nitrogen mustard), vincristine, and procarbazine (MOP) for recurrent glioma." | 9.08 | Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results. ( Buckner, JC; Burch, PA; Dinapoli, RP; Galanis, E; Mailliard, JA; Morton, RF; Novotny, PJ; Rowland, KM; Schaefer, PL; Scheithauer, BW; Vukov, AM, 1998) |
| "We undertook a phase II study of combination chemotherapy with mechlorethamine (nitrogen mustard) 6 mg/m2 intravenously day 1 and day 8, vincristine 2 mg intravenously day 1 and day 8, and procarbazine 100 mg/m2 orally days 1 through 14 (MOP) in adults with recurrent high-grade glioma." | 9.06 | Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study. ( Baptista, J; Clark, K; Coyle, T; Graziano, S; King, R; Kirshner, J; Newman-Palmer, N; Poiesz, B; Scalzo, A; Winfield, J, 1990) |
| "Of 42 patients who had mycosis fungoides (MF) confined to the skin with or without dermatopathic lymphadenopathy, 21 were treated with topically applied mechlorethamine hydrochloride and 21 with total-skin electron-beam irradiation." | 9.05 | Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy. ( Hamminga, B; Noordijk, EM; van Vloten, WA, 1982) |
| "Objectives The goals of this retrospective study were to evaluate the use of mechlorethamine, vincristine, melphalan and prednisolone (MOMP) chemotherapy for rescue of feline lymphoma, to describe the protocol's toxicity and to determine prognostic indicators for progression-free survival." | 7.88 | Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma. ( Martin, OA; Price, J, 2018) |
| "Previous investigators have reported responses in 52% of patients treated with mechlorethamine (nitrogen mustard), vincristine, and procarbazine (MOP) for recurrent glioma." | 5.08 | Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results. ( Buckner, JC; Burch, PA; Dinapoli, RP; Galanis, E; Mailliard, JA; Morton, RF; Novotny, PJ; Rowland, KM; Schaefer, PL; Scheithauer, BW; Vukov, AM, 1998) |
| "We undertook a phase II study of combination chemotherapy with mechlorethamine (nitrogen mustard) 6 mg/m2 intravenously day 1 and day 8, vincristine 2 mg intravenously day 1 and day 8, and procarbazine 100 mg/m2 orally days 1 through 14 (MOP) in adults with recurrent high-grade glioma." | 5.06 | Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study. ( Baptista, J; Clark, K; Coyle, T; Graziano, S; King, R; Kirshner, J; Newman-Palmer, N; Poiesz, B; Scalzo, A; Winfield, J, 1990) |
| "Of 42 patients who had mycosis fungoides (MF) confined to the skin with or without dermatopathic lymphadenopathy, 21 were treated with topically applied mechlorethamine hydrochloride and 21 with total-skin electron-beam irradiation." | 5.05 | Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy. ( Hamminga, B; Noordijk, EM; van Vloten, WA, 1982) |
| "Objectives The goals of this retrospective study were to evaluate the use of mechlorethamine, vincristine, melphalan and prednisolone (MOMP) chemotherapy for rescue of feline lymphoma, to describe the protocol's toxicity and to determine prognostic indicators for progression-free survival." | 3.88 | Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma. ( Martin, OA; Price, J, 2018) |
| "A retrospective review of patients with Hodgkin's disease treated at Stanford University Medical Center was undertaken to determine if, within the pediatric population, children < or = 10 years of age have a unique prognosis and response to treatment." | 2.67 | Hodgkin's disease in the very young. ( Cleary, SF; Donaldson, SS; Link, MP, 1994) |
| "Thirty seven Hodgkin's lymphoma patients with recurrence after first remission induced by radiation therapy and/or chemotherapy with mustine, oncovin, procarbazine and prednisolone (MOPP) were randomised to treat with a new combination chemotherapy comprising of doxorubicin, oncovin, procarbazine and prednisolone (DOPP)." | 2.65 | A new combination chemotherapy for recurrent Hodgkin's lymphoma. ( Ahmed, Q; Rahim, MA; Sarma, SK, 1982) |
| "The treatment strategies of Hodgkin's lymphoma (HL) are different according to clinical stage and risk factors, yet the optimal treatment strategy remains unclear." | 1.34 | [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. ( Hu, DS; Hu, S; Song, QB; Tan, WY; Wei, L; Zeng, FY; Zhou, LQ, 2007) |
| "Sixteen patients with Hodgkin's disease were treated with MOPP/ABVD and filgrastim support between January 1992 and March 1994." | 1.30 | G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease. ( Gustavsson, A, 1997) |
| "Optimal treatment for Hodgkin's disease during childhood is unknown." | 1.30 | Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy. ( Farah, RA; Geara, F; Hajjar, T; Khogali, M; Muwakkit, S; Nabbout, B; Shabb, NS, 1999) |
| "In patients with advanced Hodgkin's disease (HD), the alternation of MOPP with ABVD or hybrid MOPP/ABVD are associated with a high CR rate and a high probability of 5-year survival." | 1.29 | Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease. ( Aversa, S; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Mazzarotto, R; Pappagallo, GL; Salvagno, L; Scarzello, G; Sorarù, M; Sotti, G, 1995) |
| "Two cases of malignant schwannoma are reported 13 and 15 years following combined modality treatment for Hodgkin's disease." | 1.29 | Malignant schwannoma following treatment for Hodgkin's disease. ( Bridges, LR; Cartwright, SC; Dodwell, DJ; Fisher, PM; Stone, J, 1994) |
| "Fifty-three patients with advanced Hodgkin's disease, most of them previously treated, received 8 to 16 courses of modified MOPP regimens (nitrogen mustard replaced by trichlormethine in arm A, with addition of vinblastine to the 4-drug regimen in arm B, and alternation of three drugs--trichlormethine, vincristine, and prednisone--with probably non-cross resistant two drugs--vinblastine and procarbazine in arm C)." | 1.28 | Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation. ( Bohunický, L; Cerný, V; Gyárfás, J; Koza, I; Mardiak, J; Svancárová, L, 1989) |
| "Although most patients with Hodgkin's disease refractory to MOPP treatment will respond to either ABVD or B-CAVe chemotherapy, subsequent long-term disease-free survival is unusual." | 1.27 | Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. ( Harker, WG; Kushlan, P; Rosenberg, SA, 1984) |
| "Thymic hyperplasia is a poorly understood, apparently benign process that may be confused with recurrent lymphoma." | 1.27 | Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature. ( Edington, H; Longo, DL; Pass, H; Roth, JA; Salwitz, J, 1986) |
| "Patients with diffuse histiocytic lymphoma who achieved a histologically proven complete remission after 6 months of treatment without maintenance have remained disease-free whereas those with nodular poorly differentiated lymphocytic and diffuse well-differentiated lymphocytic lymphomas have demonstrated a pattern of continuous late recurrence." | 1.25 | Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy. ( Canellos, GP; Chabner, BA; DeVita, VT; Schein, PS; Young, RC, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (61.73) | 18.7374 |
| 1990's | 21 (25.93) | 18.2507 |
| 2000's | 6 (7.41) | 29.6817 |
| 2010's | 2 (2.47) | 24.3611 |
| 2020's | 2 (2.47) | 2.80 |
| Authors | Studies |
|---|---|
| Purvis, KN | 1 |
| Swanson, HD | 1 |
| Niloy, KK | 1 |
| Zhou, Y | 1 |
| Panetta, JC | 1 |
| Crews, KR | 1 |
| Flerlage, JE | 1 |
| Zimmerman, K | 1 |
| Walsh, KA | 1 |
| Ferrari, JT | 1 |
| Keuler, NS | 1 |
| Atherton, MJ | 1 |
| Lenz, JA | 1 |
| Martin, OA | 1 |
| Price, J | 1 |
| Nagai, H | 1 |
| Lee, J | 1 |
| Viakhireva, N | 1 |
| Cesca, C | 1 |
| Lee, P | 1 |
| Kohler, S | 1 |
| Hoppe, RT | 1 |
| Kim, YH | 1 |
| Niu, Y | 1 |
| Shi, YK | 1 |
| He, XH | 1 |
| Feng, FY | 1 |
| Zhou, LQ | 2 |
| Gu, DZ | 1 |
| DENK, W | 2 |
| KARRER, K | 3 |
| WURNIG, P | 5 |
| SCHEUBA, G | 2 |
| INCH, WR | 2 |
| McCREDIE, JA | 2 |
| IZUO, M | 1 |
| CLIFFORD, P | 1 |
| BHARDWAJ, BV | 1 |
| WHITTAKER, LR | 1 |
| Yamanaka, R | 1 |
| Shinbo, Y | 1 |
| Sano, M | 1 |
| Homma, J | 1 |
| Tsuchiya, N | 1 |
| Yajima, N | 1 |
| Tamura, T | 1 |
| Hondoh, H | 1 |
| Takahashi, H | 1 |
| Morii, K | 1 |
| Onda, K | 1 |
| Tanaka, R | 1 |
| Tan, WY | 1 |
| Hu, DS | 1 |
| Zeng, FY | 1 |
| Song, QB | 1 |
| Hu, S | 1 |
| Wei, L | 1 |
| Cohn, I | 1 |
| Gassmann, W | 1 |
| Schmitz, N | 1 |
| Löffler, H | 1 |
| Bartual, J | 1 |
| Roquette, J | 1 |
| Gil, M | 1 |
| Magro, E | 1 |
| Bascuas, JL | 1 |
| Harker, WG | 1 |
| Kushlan, P | 1 |
| Rosenberg, SA | 2 |
| Wade, PM | 1 |
| Smith, RE | 1 |
| Johns, ME | 1 |
| Micaily, B | 1 |
| Vonderheid, EC | 1 |
| Brady, LW | 1 |
| Schmitt, K | 1 |
| Tulzer, W | 1 |
| Heinz, R | 1 |
| Hanak, H | 1 |
| Kovalenko, NS | 1 |
| Fokina, NT | 2 |
| Vorob'ev, AI | 1 |
| Brilliant, MD | 1 |
| Fil'kova, EM | 1 |
| Cramer, P | 1 |
| Schaison, G | 1 |
| Andrieu, JM | 2 |
| Boiron, M | 2 |
| Bernard, J | 2 |
| Rahim, MA | 1 |
| Sarma, SK | 1 |
| Ahmed, Q | 1 |
| Gallmeier, WM | 1 |
| Bruntsch, U | 1 |
| Hamminga, B | 1 |
| Noordijk, EM | 1 |
| van Vloten, WA | 1 |
| Timothy, AR | 1 |
| Sutcliffe, SB | 1 |
| Lister, TA | 1 |
| Wrigley, PF | 1 |
| Jones, AE | 1 |
| Cleary, SF | 1 |
| Link, MP | 2 |
| Donaldson, SS | 2 |
| Salvagno, L | 1 |
| Sorarù, M | 1 |
| Sotti, G | 1 |
| Aversa, S | 1 |
| Chiarion Sileni, V | 1 |
| Mazzarotto, R | 1 |
| Scarzello, G | 1 |
| Bianco, A | 1 |
| Pappagallo, GL | 1 |
| Fiorentino, MV | 1 |
| Herrmann, JJ | 1 |
| Roenigk, HH | 1 |
| Hurria, A | 1 |
| Kuzel, TM | 1 |
| Samuelson, E | 1 |
| Rademaker, AW | 1 |
| Rosen, ST | 1 |
| Krementz, ET | 1 |
| Carter, RD | 1 |
| Sutherland, CM | 1 |
| Muchmore, JH | 1 |
| Ryan, RF | 1 |
| Creech, O | 1 |
| Hagemeister, FB | 2 |
| Purugganan, R | 1 |
| Fuller, L | 1 |
| McLaughlin, P | 1 |
| Swan, F | 1 |
| Romaguera, J | 1 |
| Rodriguez, M | 1 |
| Cabanillas, F | 2 |
| Fisher, PM | 1 |
| Dodwell, DJ | 1 |
| Bridges, LR | 1 |
| Cartwright, SC | 1 |
| Stone, J | 1 |
| Gosselin, M | 1 |
| Podgorsak, EB | 1 |
| Evans, MD | 1 |
| Pla, M | 1 |
| Shenouda, G | 1 |
| Jenkin, D | 1 |
| Greenberg, M | 1 |
| Fitzgerald, A | 1 |
| Newman, JM | 1 |
| Rindler, JM | 1 |
| Bergfeld, WF | 1 |
| Brydon, JK | 1 |
| Gustavsson, A | 1 |
| Lamb, PM | 1 |
| Menaker, GM | 1 |
| Moy, RL | 1 |
| Galanis, E | 1 |
| Buckner, JC | 1 |
| Burch, PA | 1 |
| Schaefer, PL | 1 |
| Dinapoli, RP | 1 |
| Novotny, PJ | 1 |
| Scheithauer, BW | 1 |
| Rowland, KM | 1 |
| Vukov, AM | 1 |
| Mailliard, JA | 1 |
| Morton, RF | 1 |
| Arranz, R | 1 |
| Gil-Fernández, JJ | 1 |
| Muñoz, E | 1 |
| Acevedo, A | 1 |
| Sobrino, MP | 1 |
| Fernández-Rañada, JM | 1 |
| Lucas, JB | 1 |
| Horwitz, SM | 1 |
| Horning, SJ | 1 |
| Sayegh, A | 1 |
| Wu, HG | 1 |
| Kim, IH | 1 |
| Ha, SW | 1 |
| Park, CI | 1 |
| Bang, YJ | 1 |
| Huh, DS | 1 |
| Muwakkit, S | 1 |
| Geara, F | 1 |
| Nabbout, B | 1 |
| Farah, RA | 1 |
| Shabb, NS | 1 |
| Hajjar, T | 1 |
| Khogali, M | 1 |
| Wilder, RB | 1 |
| Schlembach, PJ | 1 |
| Jones, D | 1 |
| Chronowski, GM | 1 |
| Ha, CS | 1 |
| Younes, A | 1 |
| Barista, I | 1 |
| Cox, JD | 1 |
| Chisesi, T | 1 |
| Federico, M | 1 |
| Levis, A | 1 |
| Deliliers, GL | 1 |
| Gobbi, PG | 1 |
| Santini, G | 1 |
| Luminari, S | 1 |
| Linfomi, MB | 1 |
| Mensi, F | 1 |
| Bombara, R | 1 |
| Massari, A | 1 |
| Sala, F | 1 |
| Visca, U | 1 |
| Horner, RJ | 1 |
| Chaffey, JT | 1 |
| Rosenthal, DS | 1 |
| Moloney, WC | 1 |
| Cangir, A | 2 |
| van Eys, J | 2 |
| Berry, DH | 1 |
| Hvizdala, E | 1 |
| Morgan, SK | 1 |
| Weller, SA | 1 |
| Glatstein, E | 1 |
| Kaplan, HS | 1 |
| Schein, PS | 1 |
| Chabner, BA | 1 |
| Canellos, GP | 1 |
| Young, RC | 1 |
| DeVita, VT | 1 |
| Jacquillat, C | 1 |
| Weil, M | 1 |
| Auclerc, G | 1 |
| Desprez-Curely, JP | 1 |
| Chastang, C | 1 |
| Garçon, C | 1 |
| Chantalou, JP | 1 |
| Gemon-Auclerc, MF | 1 |
| Delobel, J | 1 |
| Dana, M | 1 |
| Tanzer, J | 1 |
| Teillet, F | 1 |
| Izrael, V | 1 |
| Chelloul, N | 1 |
| Weisgerber, C | 1 |
| De Heaulme, M | 1 |
| Oza, AM | 1 |
| Ganesan, TS | 1 |
| Dorreen, M | 1 |
| Johnson, PW | 1 |
| Waxman, J | 1 |
| Gregory, W | 1 |
| Lim, J | 1 |
| Wright, J | 1 |
| Dadiotis, L | 1 |
| Barbounis, V | 1 |
| Hines, JR | 1 |
| Błasińska-Morawiec, M | 1 |
| Płuzańska, A | 1 |
| Krykowski, E | 1 |
| Robak, T | 1 |
| Mrówka, I | 1 |
| Anderson, H | 1 |
| Crowther, D | 1 |
| Deakin, DP | 1 |
| Ryder, WD | 1 |
| Radford, JA | 1 |
| Coyle, T | 1 |
| Baptista, J | 1 |
| Winfield, J | 1 |
| Clark, K | 1 |
| Poiesz, B | 1 |
| Kirshner, J | 1 |
| Scalzo, A | 1 |
| Newman-Palmer, N | 1 |
| King, R | 1 |
| Graziano, S | 1 |
| Cunningham, D | 1 |
| Hepplestone, A | 1 |
| Gilchrist, NL | 1 |
| Dagg, JH | 1 |
| Evans, IL | 1 |
| Soukop, M | 1 |
| Kretschmar, CS | 1 |
| Tarbell, NJ | 1 |
| Kupsky, W | 1 |
| Lavally, BL | 1 |
| Loeffler, JS | 1 |
| Wolfe, L | 1 |
| Strand, R | 1 |
| Scott, RM | 1 |
| Sallan, SE | 1 |
| Koza, I | 1 |
| Bohunický, L | 1 |
| Svancárová, L | 1 |
| Mardiak, J | 1 |
| Gyárfás, J | 1 |
| Cerný, V | 1 |
| Colonna, P | 1 |
| Kubisz, P | 1 |
| Malou, M | 1 |
| Zouaoui, Z | 1 |
| Abad, MT | 1 |
| Touhami, M | 1 |
| Faid, L | 1 |
| Willett, CG | 1 |
| Linggood, RM | 1 |
| Leong, JC | 1 |
| Miketic, LM | 1 |
| Stracher, MA | 1 |
| Skates, SJ | 1 |
| Kushner, DC | 1 |
| Baram, TZ | 1 |
| Bruner, JM | 1 |
| Martinez-Prieto, J | 1 |
| Edington, H | 1 |
| Salwitz, J | 1 |
| Longo, DL | 1 |
| Roth, JA | 1 |
| Pass, H | 1 |
| Griffen, WO | 1 |
| Humphrey, L | 1 |
| Sosin, H | 1 |
| Reilly, CJ | 1 |
| Han, T | 1 |
| Stutzman, L | 1 |
| Slack, NH | 1 |
| Webster, J | 1 |
| Hill, GJ | 1 |
| Larsen, RR | 1 |
| Humphrey, LJ | 1 |
| Jewell, WR | 1 |
| Olweny, CL | 1 |
| Ziegler, JL | 1 |
| Smith, JP | 1 |
| Rutledge, F | 1 |
| Burns, BC | 1 |
| Soffar, S | 1 |
| Reilly, MM | 1 |
| Fitzpatrick, PJ | 1 |
| Smirnova, IN | 1 |
| Crassweller, PO | 1 |
| Ley, DC | 1 |
| Ranking, GN | 1 |
| Perez, CA | 1 |
| Olson, J | 1 |
5 reviews available for mechlorethamine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[Treatment strategy of Hodgkin lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; B | 2014 |
[The practice of chemotherapy with the DeVita protocol].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 1982 |
Response of esthesioneuroblastoma to chemotherapy. Report of five cases and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; | 1984 |
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined | 1998 |
The prognosis and management of recurrent abdominal malignancies.
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Agents; Bile Duct Neoplasms; Chemotherapy, Ca | 1969 |
13 trials available for mechlorethamine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combi | 2007 |
A new combination chemotherapy for recurrent Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Therapy, Co | 1982 |
Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy.
Topics: Administration, Topical; Adult; Aged; Female; Humans; Male; Mechlorethamine; Middle Aged; Mycosis Fu | 1982 |
The management of stage IIIA Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di | 1980 |
Hodgkin's disease in the very young.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo | 1994 |
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Female; Glioma; | 1998 |
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous | 1999 |
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diseas | 2002 |
ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Daca | 2002 |
[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; H | 1991 |
A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 1991 |
Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; G | 1990 |
Treatment of histiocytic lymphoma in Uganda adults.
Topics: Adult; Cyclophosphamide; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Hydrazines; | 1971 |
63 other studies available for mechlorethamine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Child; Doxorubicin; Hodg | 2023 |
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Doxorubicin; Lymphoma; | 2023 |
Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Disease-Free Survival; | 2018 |
Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Diagnosis, Differential; Female; Hand Dermatoses; Humans; In | 2008 |
[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2008 |
[Chemotherapy in prevention of recurrence of carcinoma].
Topics: Antineoplastic Agents; Humans; Mechlorethamine; Neoplasm Recurrence, Local; Nitrogen Mustard Compoun | 1956 |
[Results & fundamentals of recurrence prevention with mitomen in radical surgery of malignant tumors, as shown in bronchial carcinoma].
Topics: Bronchi; Bronchial Neoplasms; Carcinoma, Bronchogenic; Mechlorethamine; Neoplasm Recurrence, Local; | 1958 |
[Preliminary results and fundamentals of recurrence prevention with chemotherapy in radical surgery of malignant tumors in bronchial carcinoma].
Topics: Bronchi; Bronchial Neoplasms; Carcinoma, Bronchogenic; Mechlorethamine; Neoplasm Recurrence, Local; | 1958 |
[Preliminary results of chemotherapeutic prophylaxis of postoperative recurrence of bronchial carcinoma with mitomen].
Topics: Bronchi; Bronchial Neoplasms; Carcinoma, Bronchogenic; Mechlorethamine; Neoplasm Recurrence, Local; | 1959 |
[Chemotherapy as an attempt at prevention of recurrence after carcinoma surgery].
Topics: Biomedical Research; Carcinoma; Humans; Mechlorethamine; Neoplasm Recurrence, Local; Neoplasms; Nitr | 1959 |
[Preliminary results of chemotherapeutic prevention of recurrences with mitomen in patients with bronchial carcinoma after surgery].
Topics: Antineoplastic Agents; Biomedical Research; Carcinoma, Bronchogenic; Lung Neoplasms; Mechlorethamine | 1960 |
Effect of wound irrigation with nitrogen mustard or Clorpactin XCB on local recurrence of rat and mouse tumors.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Carcinoma; Carcinoma 256, Walker; Mechlorethamine | 1963 |
[Changes in the clinical problems of bronchial carcinoma in the past decade. VIII. Results of chemotherapeutic prevention of recurrence].
Topics: Bronchi; Bronchial Neoplasms; Carcinoma, Bronchogenic; Lung Neoplasms; Mechlorethamine; Neoplasm Rec | 1962 |
[SUPPLEMENTARY THERAPEUTIC MEASURES TO PREVENT THE RECURRENCE OF BREAST CANCER USED IN ASSOCIATION WITH RADICAL SURGERY].
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Humans; Mastectomy; Mechlorethamine; Mito | 1964 |
EFFECT OF LOCAL CHEMOTHERAPY OR A SMALL DOSE OF RADIOTHERAPY ON CANCER RECURRENCE.
Topics: Animals; Anti-Infective Agents, Local; Breast Neoplasms; Carcinoma; Halogens; Humans; Hydrocarbons, | 1964 |
INTENSIVE NITROGEN MUSTARD THERAPY WITH ABDOMINAL AORTIC OCCLUSION IN NASOPHARYNGEAL CARCINOMA.
Topics: Adenocarcinoma; Antineoplastic Agents; Aorta; Aorta, Abdominal; Busulfan; Carcinoma; Carcinoma, Squa | 1965 |
[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 2007 |
Implantation in cancer of the colon.
Topics: Animals; Antisepsis; Carcinoma, Brown-Pearce; Colonic Neoplasms; Dextrans; Dimethyl Sulfoxide; In Vi | 1967 |
Twelve years of experience with cytotoxic therapy in malignant tumors of the neck and head.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 1982 |
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1984 |
Combined moderate dose electron beam radiotherapy and topical chemotherapy for cutaneous T-Cell lymphoma.
Topics: Administration, Topical; Adult; Aged; Electrons; Female; Humans; Male; Mechlorethamine; Middle Aged; | 1983 |
[Second tumor following Hodgkin's disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Presc | 1984 |
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Dis | 1984 |
[Recurrences in lymphogranulomatosis].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Fe | 1983 |
[Combined therapy of lymphogranulomatosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Drug The | 1981 |
[Hodgkin's disease in childhood: long term results].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Therapy, C | 1982 |
[Drug therapy of Hodgkin's disease].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho | 1981 |
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc | 1995 |
Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.
Topics: Biopsy; Carmustine; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Mechlorethamine; Middle | 1995 |
Regional chemotherapy for melanoma. A 35-year experience.
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Combined Modality T | 1994 |
Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1994 |
Malignant schwannoma following treatment for Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female | 1994 |
A technique using parallel-opposed high energy electron beams for reirradiation of tumors near the spinal cord.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham | 1993 |
Second malignant tumours in childhood Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Protocols; Cohort | 1996 |
Stevens-Johnson syndrome associated with topical nitrogen mustard therapy.
Topics: Administration, Cutaneous; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Female | 1997 |
G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antine | 1997 |
Multiple basal cell carcinomas of the limb after adjuvant treatment of melanoma with isolated limb perfusion.
Topics: Antineoplastic Agents, Alkylating; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Chemotherapy, Canc | 1998 |
Gemcitabine is active in relapsed Hodgkin's disease.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; D | 1999 |
Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl | 1999 |
[The chordoma. Description of 2 clinical cases and results of oncolytic chemotherapy].
Topics: Adult; Aged; Brain Neoplasms; Chordoma; Coccyx; Cyclophosphamide; Humans; Male; Mechlorethamine; Neo | 1979 |
Relapse of Hodgkin disease after extended-field radiotherapy.
Topics: Adolescent; Adult; Aged; Bone Marrow; Child; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lym | 1978 |
Combination chemotherapy with MOPP in children with recurrent brain tumors.
Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Drug Therapy, Combinati | 1978 |
Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment.
Topics: Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Metastasis; Neoplasm Recurrence, Lo | 1976 |
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
Topics: Antineoplastic Agents; Bone Marrow; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymph Nodes | 1975 |
Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up).
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore | 1975 |
Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microgl | 1992 |
Intravenous nitrogen mustard given immediately after mastectomy: possible effect on local recurrence.
Topics: Breast Neoplasms; Female; Humans; Injections, Intravenous; Mastectomy; Mechlorethamine; Neoplasm Rec | 1992 |
Failure of conventional chemotherapy in aggressive lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1987 |
Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Pres | 1989 |
Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu | 1989 |
[Treatment of Hodgkin's disease by chemotherapy with MOPP alone. Long-term results].
Topics: Adolescent; Adult; Algeria; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Follow-Up | 1986 |
Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relationship | 1988 |
Salvage chemotherapy for recurrent primary brain tumors in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Chi | 1988 |
Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1987 |
Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Hodgkin Disease | 1986 |
Reticulum cell sarcoma. A review of radiotherapeutic experience.
Topics: Adolescent; Adult; Aged; Chlorambucil; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Mal | 1972 |
Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
Topics: Adenocarcinoma; Amides; Androgens; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Estrogens; | 1972 |
Chemotherapy for recurrent carcinoma of the breast.
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Hepatic Artery; Humans; Injections, | 1972 |
Systemic chemotherapy for carcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Fema | 1967 |
Adjuvant chemotherapy in primary treatment of breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Female; Humans; Mastectomy; Mechlorethami | 1969 |
[Results of treatment of tonsillar tumors by olivomycin].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Chlorpromazine; Cyclophosp | 1969 |
The use of nitrogen mustard for prevention of bladder tumor recurrence.
Topics: Animals; Carcinoma, Transitional Cell; Dogs; Humans; Mechlorethamine; Neoplasm Recurrence, Local; Th | 1968 |
Preoperative irradiation and chemotherapy in the prevention of surgical failures: experimental observations on an animal tumor model.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Lymphoma, Non-Hodgkin; Mechlorethamine; Mice; Mode | 1969 |